Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: Workshop summary report

Author:

Chen Mei-Ling,Shah Vinod P.,Ganes Derek,Midha Kamal K.,Caro James,Nambiar Prabu,Rocci Mario L.,Thombre Avinash G.,Abrahamsson Bertil,Conner Dale,Davit Barbara,Fackler Paul,Farrell Colm,Gupta Suneel,Katz Russell,Mehta Mehul,Preskorn Sheldon H.,Sanderink Gerard,Stavchansky Salomon,Temple Robert,Wang Yaning,Winkle Helen,Yu Lawrence

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference14 articles.

1. Seizures and bupropion: a review;Davidson;J. Clin. Psychiatry,1989

2. A randomized double-blind, placebo-controlled, 10-way cross-over study shows that a new zolpidem modified-release formulation improves sleep maintenance compared to standard zolpidem;Hindmarch;Sleep,2004

3. Should bupropion dosage be adjusted based upon therapeutic drug monitoring?;Preskorn;Psychopharmacol. Bull.,1991

4. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia;Roth;Sleep Med.,2006

5. Acute tolerance to methylphenidate in the treatment of attention deficit hypersensitivity disorder in children;Swanson;Clin. Pharmacol. Ther.,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3